ALPA — Alpa Laboratories Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapTurnaround

Annual income statement for Alpa Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,123	930	1,087	1,125	1,058
Cost of Revenue
Gross Profit	362	334	365	380	315
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	1,033	862	1,026	1,099	1,046
Operating Profit	90	67.5	61.5	26	12
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	196	159	207	257	167
Provision for Income Taxes
Net Income After Taxes	141	126	168	195	150
Net Income Before Extraordinary Items
Net Income	141	126	168	195	150
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	141	126	168	195	150
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	6.7	5.98	7.97	9.29	7.13